Dr Lindsay Fraser

Biography

  Lindsay joined the team in 2012 to establish the induced pluripotent stem cell (iPSC) core facility. She now has responsibility for leading the cell therapy research and development projects, and in the translation of research protocols to regulatory compliant GMP manufacturing processes. The development team also design and optimise complementary cell characterisation assays to monitor cell health during processing.  Lindsay finds her role is constantly evolving, in response to novel advances in regenerative medicine. She has a passion for the development and implementation of new technology and in helping cell therapy products reach the clinic.     She has experience in regenerative medicine, GMP processing and cellular therapy application, working across clinical, academic and commercial sectors including the Scottish National Blood Transfusion Service, Edinburgh University (PhD), Miltenyi Biotec and Biobest Laboratories. Lindsay loves the great outdoors, festivals and time out with friends and family

Research Interest

e development team also design and optimise complementary cell characterisation assays to monitor cell health during processing.  Lindsay finds her role is constantly evolving, in response to novel advances in regenerative medicine